Nifty
:
22147.00
Sensex
:
73088.33
151.15 (0.69%)
599.34 (0.83%)
Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Deccan Health Care Ltd.

Pharmaceuticals & Drugs

Rating :
32/99

BSE: 542248 | NSE: Not Listed

NSE BSE
26.00
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  26.99
  •  26.99
  •  25.76
  •  26.54
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  156
  •  22.70
  •  42.00
  •  23.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 52.98
  • 116.18
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 52.65
  • N/A
  • 0.57

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 16.12%
  • 19.89%
  • 52.30%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 11.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.39
  • 0.35
  • 10.05

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -33.85
  • -0.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -49.84
  • -2.63

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 160.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 0.68

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 19.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
15.34
8.65
77.34%
17.18
11.77
45.96%
11.24
8.75
28.46%
0.00
0.00
0
Expenses
14.12
8.85
59.55%
16.14
10.99
46.86%
10.43
8.09
28.92%
0.00
0.00
0
EBITDA
1.22
-0.21
-
1.04
0.78
33.33%
0.81
0.65
24.62%
0.00
0.00
0
EBIDTM
7.96%
-2.38%
6.07%
6.64%
7.19%
7.44%
0.00%
0.00%
Other Income
0.00
0.01
-100.00%
0.00
0.00
0
0.01
0.00
0
0.00
0.00
0
Interest
0.04
0.04
0.00%
0.00
0.03
-100.00%
0.02
0.02
0.00%
0.00
0.00
0
Depreciation
0.40
0.36
11.11%
0.32
0.36
-11.11%
0.39
0.36
8.33%
0.00
0.00
0
PBT
0.79
-0.59
-
0.72
0.40
80.00%
0.40
0.27
48.15%
0.00
0.00
0
Tax
0.26
-0.13
-
0.18
0.10
80.00%
0.10
0.07
42.86%
0.00
0.00
0
PAT
0.53
-0.46
-
0.54
0.30
80.00%
0.30
0.20
50.00%
0.00
0.00
0
PATM
3.42%
-5.34%
3.15%
2.57%
2.66%
2.30%
0.00%
0.00%
EPS
0.26
-0.27
-
0.32
0.18
77.78%
0.18
0.12
50.00%
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Net Sales
-
45.02
33.17
33.78
Net Sales Growth
-
35.73%
-1.81%
 
Cost Of Goods Sold
-
24.96
14.35
18.43
Gross Profit
-
20.05
18.82
15.35
GP Margin
-
44.54%
56.74%
45.44%
Total Expenditure
-
42.99
27.82
31.74
Power & Fuel Cost
-
0.42
0.44
0.42
% Of Sales
-
0.93%
1.33%
1.24%
Employee Cost
-
3.25
2.20
2.92
% Of Sales
-
7.22%
6.63%
8.64%
Manufacturing Exp.
-
1.91
1.76
1.12
% Of Sales
-
4.24%
5.31%
3.32%
General & Admin Exp.
-
1.46
0.92
1.13
% Of Sales
-
3.24%
2.77%
3.35%
Selling & Distn. Exp.
-
10.97
7.82
6.77
% Of Sales
-
24.37%
23.58%
20.04%
Miscellaneous Exp.
-
0.00
0.34
0.96
% Of Sales
-
0%
1.03%
2.84%
EBITDA
-
2.03
5.35
2.04
EBITDA Margin
-
4.51%
16.13%
6.04%
Other Income
-
0.02
0.22
0.06
Interest
-
0.11
0.15
0.11
Depreciation
-
1.43
1.47
1.47
PBT
-
0.52
3.94
0.52
Tax
-
0.15
0.22
0.13
Tax Rate
-
28.85%
40.74%
25.00%
PAT
-
0.36
0.32
0.39
PAT before Minority Interest
-
0.36
0.32
0.39
Minority Interest
-
0.00
0.00
0.00
PAT Margin
-
0.80%
0.96%
1.15%
PAT Growth
-
12.50%
-17.95%
 
EPS
-
0.18
0.16
0.19

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Shareholder's Funds
81.56
76.94
76.62
Share Capital
17.04
15.71
15.71
Total Reserves
64.52
61.23
60.91
Non-Current Liabilities
3.31
3.19
2.93
Secured Loans
0.26
0.83
0.45
Unsecured Loans
0.92
0.13
0.21
Long Term Provisions
0.09
0.14
0.14
Current Liabilities
11.98
10.49
12.71
Trade Payables
8.43
5.81
5.66
Other Current Liabilities
2.77
4.15
5.05
Short Term Borrowings
0.00
0.00
0.00
Short Term Provisions
0.78
0.53
2.00
Total Liabilities
96.85
90.62
92.26
Net Block
16.85
18.53
19.87
Gross Block
33.24
33.49
33.60
Accumulated Depreciation
16.39
14.96
13.73
Non Current Assets
21.00
22.67
25.81
Capital Work in Progress
0.00
0.00
0.07
Non Current Investment
0.00
0.00
0.00
Long Term Loans & Adv.
1.78
1.77
3.50
Other Non Current Assets
2.37
2.37
2.37
Current Assets
75.86
67.96
66.46
Current Investments
0.00
0.00
0.00
Inventories
46.75
46.50
44.98
Sundry Debtors
12.05
12.82
12.47
Cash & Bank
1.43
2.67
3.22
Other Current Assets
15.62
0.01
0.03
Short Term Loans & Adv.
15.34
5.95
5.76
Net Current Assets
63.88
57.47
53.75
Total Assets
96.86
90.63
92.27

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-6.61
-0.57
0.22
PBT
0.52
3.94
0.52
Adjustment
0.78
-1.78
1.57
Changes in Working Capital
-7.69
-2.48
-1.73
Cash after chg. in Working capital
-6.39
-0.32
0.36
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.22
-0.25
-0.14
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
0.25
-0.05
-0.07
Net Fixed Assets
0.25
0.18
Net Investments
0.00
0.00
Others
0.00
-0.23
Cash from Financing Activity
5.12
0.07
-0.37
Net Cash Inflow / Outflow
-1.23
-0.56
-0.22
Opening Cash & Equivalents
2.67
3.22
3.45
Closing Cash & Equivalent
1.43
2.67
3.22

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
47.86
48.97
48.76
ROA
0.39%
0.35%
0.42%
ROE
0.46%
0.42%
0.51%
ROCE
0.78%
0.89%
0.81%
Fixed Asset Turnover
1.35
0.99
1.01
Receivable days
100.83
139.13
134.71
Inventory Days
378.03
503.31
486.07
Payable days
104.04
145.80
112.02
Cash Conversion Cycle
374.81
496.65
508.76
Total Debt/Equity
0.02
0.02
0.01
Interest Cover
5.72
4.57
5.81

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Deccan Health Care - Quarterly Results
    6th Feb 2024, 16:21 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.